News and Announcements
Prescient Therapeutics Quarter Summary and Key Activities
- Published January 25, 2016 2:54PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
25th January 2016, ASX Announcement
Prescient Therapeutics Limited (“Prescient” or “the Company”) provides the following Appendix 4C in relation to the quarter ended 31 December 2015.
In January 2016, the Company carried out investor roadshows in the US meeting key instructions and investment advisors and also presented at Biotech Showcase 2016 in San Francisco and NobleCon12 in Florida.
Cash at 31 December 2015
Cash at the end of the quarter, as detailed in the attached Appendix 4C, was approximately $1.93 million.
Subsequent to the end of the quarter the Company has now received its 2014/2015 Research and Development Incentive Grant and Overseas Finding Grant amounting to $463,358.
Key activities during the quarter
During the quarter, the Company announced a Share Purchase Plan (SPP) fully which was underwritten up to a target amount of $1.03 million to underpin next stage development of its lead oncology costs. The SPP closed oversubscribed with $1.2 million worth of subscriptions received. All applications under the SPP were scaled back on an equal basis and a total of 17,174,368 full paid original shares were issued at $0.054 (5.5 cents) per share, being a 20% discount to the 5 day volume weighted average price (VWAP) before 23 November 2015.
To read the full announcement, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
